127 related articles for article (PubMed ID: 37682690)
1. Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors.
Adrian G; Gebre-Medhin M; Nilsson P
Acta Oncol; 2023 Nov; 62(11):1375-1383. PubMed ID: 37682690
[TBL] [Abstract][Full Text] [Related]
2. Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.
Adrian G; Carlsson H; Kjellén E; Sjövall J; Zackrisson B; Nilsson P; Gebre-Medhin M
Radiat Oncol; 2022 Jun; 17(1):107. PubMed ID: 35701827
[TBL] [Abstract][Full Text] [Related]
3. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
5. Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study.
Kristensen MH; Sørensen MK; Tramm T; Alsner J; Sørensen BS; Maare C; Johansen J; Primdahl H; Bratland Å; Kristensen CA; Andersen M; Lilja-Fischer JK; Holm AIS; Samsøe E; Hansen CR; Zukauskaite R; Overgaard J; Eriksen JG
Radiother Oncol; 2024 Apr; 193():110149. PubMed ID: 38341096
[TBL] [Abstract][Full Text] [Related]
6. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
[TBL] [Abstract][Full Text] [Related]
8. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
[TBL] [Abstract][Full Text] [Related]
9. Effect of Tumor Size and p16 Status on Treatment Outcomes - Achievement of Complete Remission in Prospectively Followed Patients with Oropharyngeal Tumors.
Slavik M; Kazda T; Selingerová I; Šána J; Ahmad P; Gurín D; Hermanová M; Novotný T; Červená R; Dymáčková R; Burkoň P; Slabý O; Šlampa P
Klin Onkol; 2019; 32(1):58-65. PubMed ID: 30764631
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
12. HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study.
Lilja-Fischer JK; Kristensen MH; Lassen P; Steiniche T; Tramm T; Stougaard M; Maare C; Johansen J; Primdahl H; Kristensen CA; Andersen M; Eriksen JG; Overgaard J
Acta Oncol; 2023 Nov; 62(11):1384-1388. PubMed ID: 37837201
[TBL] [Abstract][Full Text] [Related]
13. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
14. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
Lassen P; Lacas B; Pignon JP; Trotti A; Zackrisson B; Zhang Q; Overgaard J; Blanchard P;
Radiother Oncol; 2018 Jan; 126(1):107-115. PubMed ID: 29100700
[TBL] [Abstract][Full Text] [Related]
16. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
[TBL] [Abstract][Full Text] [Related]
17. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
18. Aptima HR-HPV Testing of Cytology Specimens Is an Effective Supplement for p16 Staining to Improve Diagnostic Accuracy for HPV-Related Oropharyngeal Squamous Cell Carcinoma.
Yang X; Hu C; Zhao H; Zhang Z; Zhao L; Yu J; Ni X; Guo H
Acta Cytol; 2023; 67(3):321-332. PubMed ID: 36513056
[TBL] [Abstract][Full Text] [Related]
19. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
[TBL] [Abstract][Full Text] [Related]
20. HPV-Related Oropharyngeal Cancer in Southern Thailand: Proportion Trend and Survival Outcome.
Saiya P; Jantharapattana K; Dechaphunkul A; Jirapongsak J; Thongsuksai P
Asian Pac J Cancer Prev; 2024 Jan; 25(1):57-64. PubMed ID: 38285767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
